Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide.
Saved in:
| Title: | Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide. |
|---|---|
| Authors: | Taktaz, Fatemeh1 (AUTHOR), Fontanella, Rosaria Anna1 (AUTHOR), Scisciola, Lucia1 (AUTHOR) lucia.scisciola@unicampania.it, Pesapane, Ada1 (AUTHOR), Basilicata, Manuela Giovanna1 (AUTHOR), Ghosh, Puja1 (AUTHOR), Franzese, Martina1 (AUTHOR), Tortorella, Giovanni1 (AUTHOR), Puocci, Armando1 (AUTHOR), Vietri, Maria Teresa2,3 (AUTHOR), Capuano, Annalisa4 (AUTHOR), Paolisso, Giuseppe1,5 (AUTHOR), Barbieri, Michelangela1 (AUTHOR) |
| Source: | Cardiovascular Diabetology. 7/10/2024, Vol. 23 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
